What do we really know about ovarian cancer risk and the 'gene mutations' considered largely responsible for increasing it? The answer is quite surprising and opens up the possibility for a radical change in how we diagnosis and treat the most lethal gynecological cancer in existence.
Conventional cancer treatments aren't working for women with breast cancer. Women are falling into a cancer industry machine only to be spit out at the other end, permanently damaged and still with no reasonable assurance of long-term survival.
Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.